Roberts R R, Zalenski R J, Mensah E K, Rydman R J, Ciavarella G, Gussow L, Das K, Kampe L M, Dickover B, McDermott M F, Hart A, Straus H E, Murphy D G, Rao R
Department of Emergency Medicine, Cook County Hospital/Rush University, Chicago, IL 60612, USA.
JAMA. 1997 Nov 26;278(20):1670-6.
More than 3 million patients are hospitalized yearly in the United States for chest pain. The cost is over $3 billion just for those found to be free of acute disease. New rapid diagnostic tests for acute myocardial infarction (AMI) have resulted in the proliferation of accelerated diagnostic protocols (ADPs) and chest pain observation units.
To determine whether use of an emergency department (ED)-based ADP can reduce hospital admission rate, total cost, and length of stay (LOS) for patients needing admission for evaluation of chest pain.
Prospective randomized controlled trial comparing admission rate, total cost, and LOS for patients treated using ADP vs inpatient controls. Total costs were determined using empirically measured resource utilization and microcosting techniques.
A large urban public teaching hospital serving a predominantly African American and Hispanic population.
A sample of 165 patients was randomly selected from a larger consecutive sample of 429 patients with chest pain concurrently enrolled in an ADP diagnostic cohort trial. Eligible patients presented to the ED with clinical findings suggestive of AMI or acute cardiac ischemia (ACI) but at low risk using a validated predictive algorithm.
Primary outcomes measured for each subject were LOS and total cost of treatment.
The hospital admission rate for ADP vs control patients was 45.2% vs 100% (P<.001). The mean total cost per patient for ADP vs control patients was $1528 vs $2095 (P<.001). The mean LOS measured in hours for ADP vs control patients was 33.1 hours vs 44.8 hours (P<.01).
In this trial, ADP saved $567 in total hospital costs per patient treated. Use of ED-based ADPs can reduce hospitalization rates, LOS, and total cost for low-risk patients with chest pain needing evaluation for possible AMI or ACI.
在美国,每年有超过300万患者因胸痛住院。仅那些被发现没有急性疾病的患者,费用就超过30亿美元。急性心肌梗死(AMI)的新型快速诊断测试导致了加速诊断方案(ADP)和胸痛观察单元的激增。
确定基于急诊科(ED)的ADP的使用是否可以降低因胸痛需要入院评估的患者的住院率、总成本和住院时间(LOS)。
前瞻性随机对照试验,比较使用ADP治疗的患者与住院对照患者的住院率、总成本和LOS。总成本使用经验测量的资源利用和微观成本核算技术确定。
一家主要为非裔美国人和西班牙裔人口服务的大型城市公立教学医院。
从429例同时参加ADP诊断队列试验的胸痛患者的较大连续样本中随机抽取165例患者作为样本。符合条件的患者因临床发现提示AMI或急性心脏缺血(ACI)而到急诊科就诊,但使用经过验证的预测算法显示风险较低。
为每个受试者测量的主要结局是LOS和治疗总成本。
ADP组与对照组患者的住院率分别为45.2%和100%(P<0.001)。ADP组与对照组患者的人均总成本分别为1528美元和2095美元(P<0.001)。ADP组与对照组患者以小时为单位测量的平均LOS分别为33.1小时和44.8小时(P<0.01)。
在本试验中,ADP为每位接受治疗的患者节省了567美元的总住院费用。基于急诊科的ADP的使用可以降低需要评估是否可能患有AMI或ACI的低风险胸痛患者的住院率、LOS和总成本。